Most cited papers from Cancer Care Northwest

Cancer Care Northwest

What are the most cited papers from Cancer Care Northwest?

The most cited paper from Cancer Care Northwest is "Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer" (Carryn M. Anderson et al., 2019), with 126 citations. Next come "A review of treatment modalities for vestibular schwannoma" (126) and "Hypermethylation of the caveolin‐1 gene promoter in prostate cancer" (125).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 10 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis Due to Concurrent Radiotherapy and Cisplatin For Head and Neck Cancer Carryn M. Anderson et al. · Journal of Clinical Oncology Open access	16 Oct 2019	126
2	A review of treatment modalities for vestibular schwannoma Benjamin J. Arthurs, Robert K. Fairbanks, John J. Demakas et al. · Neurosurgical Review	8 Feb 2011	126
3	Hypermethylation of the caveolin‐1 gene promoter in prostate cancer Cui Jiang, L. Ralph Rohr, Gregory P. Swanson et al. · The Prostate	5 Feb 2001	125
4	Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial Rodney Paul Rocconi et al. · The Lancet Oncology	30 Nov 2020	120
5	Prognostic Significance of Histology and Positive Lymph Node Involvement Following Radical Hysterectomy in Carcinoma of the Cervix O. Kenneth Macdonald, Jergin Chen, Mark W. Dodson et al. · American Journal of Clinical Oncology	21 May 2009	115
6	Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes Sheri Skerget et al. · Nature Genetics Open access129 authors	19 Aug 2024	94
7	Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer Jonathan Oh et al. · Gynecologic Oncology	24 Sep 2016	93
8	Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma Robert M Eager, Casey C. Cunningham, Neil N. Senzer et al. · BMC Cancer Open access	30 Jul 2009	82
9	Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma Carryn M. Anderson, Stephen T. Sonis, Christopher M. Lee et al. · International Journal of Radiation OncologyBiologyPhysics Open access	17 Oct 2017	81
10	Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma Nicholas Di Bella, Raymond Taetle, Kathryn S. Kolibaba et al. · Blood	20 Nov 2009	77
11	Survival Outcomes in Resected Extrahepatic Cholangiocarcinoma: Effect of Adjuvant Radiotherapy in a Surveillance, Epidemiology, and End Results Analysis Tamara Z. Vern-Gross, Anand T. Shivnani, Ke Chen et al. · International Journal of Radiation OncologyBiologyPhysics	26 Oct 2010	75
12	Survival impact of lymph node dissection in endometrial adenocarcinoma: a surveillance, epidemiology, and end results analysis D. Clayton Smith, O. Kenneth Macdonald, C. M. Lee et al. · International Journal of Gynecological Cancer Open access	11 Jul 2007	74
13	Primary care consultation behaviours of long-term, adult survivors of cancer in the UK Nada Khan, Eila K. Watson, Peter W. Rose · British Journal of General Practice Open access	Mar 2011	71
14	Phase I Trial of Sequential Administration of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small-Cell Lung Cancer John J. Nemunaitis, Thomas P. Meyers, Neil N. Senzer et al. · Molecular Therapy Open access	Jun 2006	70
15	Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis Sudheer R. Thumma, Robert K. Fairbanks, Wayne T. Lamoreaux et al. · World Journal of Surgical Oncology Open access	3 May 2012	60
16	Clinical outcomes following salvage gamma knife radiosurgery for recurrent glioblastoma Erik W. Larson · World Journal of Clinical Oncology Open access	2014	50
17	Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients Hakan Kaya, Benjamin J Peressini, Irfan Jawed et al. · International Journal of Hematology	8 Dec 2011	49
18	Clinical Outcomes of Gamma Knife Radiosurgery in the Salvage Treatment of Patients with Recurrent High-Grade Glioma Ameer L. Elaimy, Alexander R. Mackay, Wayne T. Lamoreaux et al. · World Neurosurgery	9 Feb 2013	49
19	Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study Donald Richards, Paul R. Kuefler, Carlos Roberto Becerra et al. · Investigational New Drugs	27 Aug 2009	48
20	Pomalidomide plus low‐dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure David Samuel DiCapua Siegel, Gary John Schiller, Kevin Song et al. · British Journal of Haematology Open access	6 Oct 2019	46
21	Radiotherapy and Male Breast Cancer Nicholas Andrew Madden, O. Kenneth Macdonald, Jason Andrew Call et al. · American Journal of Clinical Oncology	29 Apr 2014	41
22	Clinical Outcomes of Stereotactic Radiosurgery in the Treatment of Patients with Metastatic Brain Tumors Ameer L. Elaimy, Alexander R. Mackay, Wayne T. Lamoreaux et al. · World Neurosurgery	May 2011	40
23	Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study Michael Wang, Leslie L. Popplewell, Robert H. Collins et al. · British Journal of Haematology Open access	2 Mar 2014	36
24	Association of Rash With Outcomes in a Randomized Phase II Trial Evaluating Cetuximab in Combination With Mitoxantrone Plus Prednisone After Docetaxel for Metastatic Castration-resistant Prostate Cancer Mark T. Fleming, Guru Sonpavde, Michael A. Kolodziej et al. · Clinical Genitourinary Cancer	13 Feb 2012	33
25	Gamma Knife Treatment of Brainstem Metastases Halloran E. Peterson, Erik W. F. Larson, Robert K. Fairbanks et al. · International Journal of Molecular Sciences Open access	30 May 2014	32
26	Multimodality treatment of brain metastases: an institutional survival analysis of 275 patients Ameer L. Elaimy, Alexander R. Mackay, Wayne T. Lamoreaux et al. · World Journal of Surgical Oncology Open access	5 Jul 2011	30
27	A concise review of the efficacy of stereotactic radiosurgery in the management of melanoma and renal cell carcinoma brain metastases Peter W Hanson, Ameer L. Elaimy, Wayne T. Lamoreaux et al. · World Journal of Surgical Oncology Open access	29 Aug 2012	30
28	Intravascular ALK-Positive Anaplastic Large-Cell Lymphoma Mimicking Inflammatory Breast Carcinoma Chandra Kumar Krishnan, Stephanie R. Moline, Karl H. Anders et al. · Journal of Clinical Oncology	14 Apr 2009	27
29	FAILURE AFTER PRIMARY RADIATION OR SURGERY FOR PROSTATE CANCER: DIFFERENCES IN RESPONSE TO ANDROGEN ABLATION Gregory P. Swanson, Mark W. Riggs, John D. Earle · The Journal of Urology	2 Jul 2004	26
30	Sorafenib in locally advanced or metastatic breast cancer William John Gradishar · Expert Opinion on Investigational Drugs	23 May 2012	25
31	Does Brachytherapy Improve Survival in Addition to External Beam Radiation Therapy in Patients With High Risk Stage I and II Endometrial Carcinoma? Marcus A. Crosby, Jonathan David Tward, Anikó Szabó et al. · American Journal of Clinical Oncology	Aug 2010	25
32	Overall and cause-specific survival for mucoepidermoid carcinoma of the major salivary glands: Analysis of 2210 patients Zachary C. Taylor, Erin A. Kaya, Jeffrey D. Bunn et al. · World Journal of Clinical Oncology Open access	18 Dec 2020	23
33	Long-term follow-up of radiotherapy for prostate cancer Gregory P. Swanson, Mark W. Riggs, John D. Earle · International Journal of Radiation OncologyBiologyPhysics Open access	14 May 2004	22
34	Clinical Outcomes of Gamma Knife Radiosurgery in the Treatment of Patients with Trigeminal Neuralgia Ameer L. Elaimy, Peter W Hanson, Wayne T. Lamoreaux et al. · International Journal of Otolaryngology Open access	25 Oct 2011	21
35	Cytotoxicity ofAtriplex confertifolia Christopher J. Capua, Nick P. Hopson, Cameron M. Stewart et al. · Journal of Toxicology Open access	2010	21
36	Long-Term Efficacy of a Novel Spinal Cord Stimulation Clinical Workflow Using Kilohertz Stimulation: Twelve-Month Results From the Vectors Study John A. Hatheway, Vipul Mangal, Michael Alan Fishman et al. · Neuromodulation Technology at the Neural Interface Open access	10 Dec 2020	20
37	Gamma knife radiosurgery for movement disorders: a concise review of the literature Ameer L. Elaimy, Benjamin J. Arthurs, Wayne T. Lamoreaux et al. · World Journal of Surgical Oncology Open access	21 Jul 2010	20
38	Two-Year Tumor Outcomes of a Phase 2B, Randomized, Double-Blind Trial of Avasopasem Manganese (GC4419) Versus Placebo to Reduce Severe Oral Mucositis Owing to Concurrent Radiation Therapy and Cisplatin for Head and Neck Cancer Carryn M. Anderson, Christopher M. Lee, Deborah Saunders et al. · International Journal of Radiation OncologyBiologyPhysics Open access	17 Jun 2022	19
39	Response of Leptomeningeal Metastasis of Breast Cancer With a HER2/neu Activating Variant to Tucatinib: A Case Report Fengting Yan, Kristine J. Rinn, Jonathon A. Kullnat et al. · Journal of the National Comprehensive Cancer Network Open access	11 Apr 2022	19
40	Systemic Opioid Elimination After Implantation of an Intrathecal Drug Delivery System Significantly Reduced Health-Care Expenditures John A. Hatheway, David L. Caraway, Guy David et al. · Neuromodulation Technology at the Neural Interface	17 Feb 2015	19
41	Gamma knife radiosurgery for typical trigeminal neuralgia: An institutional review of 108 patients Christopher M. Lee, AmeerL Elaimy, AndrewF Lamm et al. · Surgical Neurology International Open access	2013	19
42	Long-Term Survival after Gamma Knife Radiosurgery in a Case of Recurrent Glioblastoma Multiforme: A Case Report and Review of the Literature Sudheer R. Thumma, Ameer L. Elaimy, Nathan Daines et al. · Case Reports in Medicine Open access	2012	19
43	Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patients Kranti A. Mapuskar et al. · Redox Biology Open access	3 Jan 2023	18
44	Gamma knife radiosurgery for essential tremor: A Case report and review of the literature Ameer L. Elaimy, John J. Demakas, Benjamin J. Arthurs et al. · World Journal of Surgical Oncology Open access	22 Mar 2010	18
45	Gamma Knife Radiosurgery for Vestibular Schwannomas Benjamin J. Arthurs, Wayne T. Lamoreaux, Alexander R. Mackay et al. · American Journal of Clinical Oncology	22 May 2010	18
46	The Vanderbilt Professional Nursing Practice Program Karen R. Robinson, Carol Eck, Becky Keck et al. · JONA The Journal of Nursing Administration	Sep 2003	18
47	Low-calorie diet induced weight loss may alter regulatory hormones and contribute to rebound visceral adiposity in obese persons with a family history of type-2 diabetes Jacquelyn L. Banasik, M Walker, Judith M. Randall et al. · Journal of the American Association of Nurse Practitioners	20 Nov 2012	18
48	Randomized, placebo‐controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomib Paul Gerard Guy Richardson et al. · eJHaem Open access	6 Apr 2020	17
49	Clinical study of a micro-implantable pulse generator for the treatment of peripheral neuropathic pain: 3-month and 6-month results from the COMFORT-randomised controlled trial John Hatheway, Alexander Hersel, Jonathan Song et al. · Regional Anesthesia & Pain Medicine Open access	31 May 2024	15
50	Multiphase Spinal Cord Stimulation in Participants With Chronic Back or Leg Pain: Results of the BENEFIT-02 Randomized Clinical Trial Leonardo Kapural, Denis G. Patterson, Sean Li et al. · Neuromodulation Technology at the Neural Interface Open access	16 Aug 2023	15

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.